Syntheses of quinconazole (SN 539 865) and fluquinconazole (SN 597 265), inhibitors of fungal ergosterol biosynthesis, were accomplished in two modes: (i) through solution-phase construction of 3-aryl-2-thioxoquinazolin-4(3H)-ones from iminophosphoranes or o-aminobenzamides and (ii) via solid-phase method based on aza-Wittigmediated annulation of iminophosphoranes.
Vol. 6, No. 5, 2000 Solution and solid-phase approaches to quinconazole and fluquinconazole-inhibitors of fungal ergosterol biosynthesis • Scheme 1. Reagents and conditions, i, Pyridine (2 equiv.), CH 2 CI 2 , room temp. (47%); ii, 2,4-CI,-C 6 H 3 NH 2 (3.5 equiv.), THF, room temp., 24 h.
Therefore, we moved to another approach to triazolylquinazolinones of type 1, which is based on synthesis of 3-aryl-2-thioxoquinazolin-4(3H)-ones 8 followed by their further elaboration to 1 (Scheme 2).
Scanning the literature on the subject we found that different methods are now at hand for chemists to synthesize 3-aryl-2-thioxoquinazolin-4(3H)-ones. General approaches include the interaction of anthranilic acids, their methyl esters, anthranilamides or isatoic anhydrides with arylisothiocyanates, 8ah methyl N-
7a,b X = NH 2 Scheme 2.
As shown in Scheme 2, in our approach to key intermediates 8 we envisaged that these compounds could be prepared by other methods, namely, implementing aza-Wittig reaction of iminophosphoranes 6a or b with a heterocumulene (CS 2 ) or even by a simpler procedure starting from o-aminobenzamides 7. Taking also into consideration a recent report of Villalgordo et al. 9 on solid-phase synthesis of 2,3-disubstituted quinazolin-4(3H)-ones, where aza-Wittig-mediated annulation reaction was involved as a key step, we planed (Scheme 2) to utilize the above-mentioned approach for synthesis of quinconazole (1a) and Scheme 4. Reagents and conditions, i, NaN0 2 , HCl (conc.), HjO, 0-5°C, 0.5 h, then NaN 3 , NaOAc, H 2 0, 15 min., room temp., then acidified with HCl (conc.) at 0°C (72% for 15a and 71% for 15b); ii, SOCI 2 , benzene, reflux, 2 h, followed by 2,4-CI 2 -C e H 3 NH 2 , pyridine, from 0°C to room temp., 1 h (82% for 16a and 67% for 16b); iii, Ph 3 P, ether, room temp., 4 h (86% for 6a and 77% for 6b); iv, CS 2 (1 equiv.) CH 2 CI 2 , 40°C, 12 h (84% for 8a and 77% for 8b); v, CS.-DMF (2:3), DBU (1 equiv.), from room temp, to 45°C, 1.5 h (71% for 8a and 74% for 8b); vi, S0 2 CI 2 , CHCI3, reflux, 1 h (51% for 17a and 41% for 17b); vii, 1,2,4-Triazole sodium salt (C 2 H 2 N 3 Na), DMF, room temp., 24 h (54% for 1a and 49% for 1b); viii, Merrifield's peptide resin (0.67 equiv., 3.3 mmol CI7g), Cs 2 C0 3 (2 equiv.), Kl (0.33 equiv.), DMF, 80°C, 9 h; ix, Ph 3 P (1 Μ in THF, 5 equiv.), room temp., 6 h; x, 2,4-Clj-C e H 3 N=C=0 (5 equiv.); CH 2 CIj, room temp., 6 h; xi, 1H-1,2,4-Triazole, THF, 50°C, 4.5 h (71% for 1a and 46% for 1b, yields are based on initial loading of the Merrifield's resin).
In another line of research the requested triazolylquinazolinones 1a and b were synthesized by using a solid-phase method (Scheme 4). Recently Villalgordo et al. 9 · 28 introduced a versatile and straightforward method to synthesize 2,3-disubstituted 4(3H)-quinazolinones. This approach combined aza-Wittig-mediated annulation reaction with a cleavage process. 29 Having o-azidobenzoic acids 15a and b in our hands (cf. Scheme 4) we followed the described procedures 930 to get compounds 1a and b through intermediacies of polymer-bound esters 18, iminophosphoranes 9 and carbodiimides 19. Eventually, treatment of resin-bound carbodiimides 19a orb with 1H-1,2,4-triazole as a nucleophile led 31 (Scheme 4) to targeted triazolylquinazolinones 1 in good (71%) yield for compound 1a and modest (46%) yield for compound 1b.
In summary, syntheses of quinconazole and fluquinconazole, inhibitors of fungal ergosterol biosynthesis, have been accomplished. Key features of these syntheses are noteworthy: a convenient solution-phase construction of 3-aryl-2-thioxoquinazolin-4(3H)-ones from iminophosphoranes or o-aminobenzamides and solid-phase approach based on aza-Wittig-mediated annulation of iminophosphoranes.
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